Member Info for billy3

Results of General Meeting



Oxford, U.K. 11 February 2022: Sensyne Health plc (LSE:SENS) today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.



The full text of the resolutions is set out in Part IV of the Notice of General Meeting in the Circular which was sent to shareholders on 26 January 2022 (the "Circular") and is available from the Company's website at https://www.sensynehealth.com/investors/shareholder-information. Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise.



Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows:



Res No.


Votes For


%


Votes Against


%


Votes Total


% of ISC


Votes Withheld*

1. Authority to issue Warrants


115,357,952


99.98%


28,664


0.02%


115,386,616


70.02


36,007

2. Disapply pre-emption rights for Warrants


115,351,779


99.97%


34,837


0.03%


115,386,616


70.02


36,007

3. General authority to allot securities


115,350,817


99.97%


35,819


0.03%


115,386,636


70.02


35,987

4. General disapplication of pre-emption rights


102,652,017


88.96%


12,734,619


11.04%


115,386,636


70.02


35,987



*A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes.



In accordance with the terms of the Note Purchase Agreement, the Company has today issued the following Conditional Warrants to the Note Purchasers under the Financing:



Gatemore 1,998,352

Lansdowne 3,597,035

Sand Grove 6,294,813

Peel Hunt 799,341









-ENDS-

ALB1...........are you intentionally being an idiot ????
Make your mind up what you think of this company and stop suggesting you have inside information.

ALB1.....you said

Today......
"Fasten seat belts time, big news coming here!”
“Been told that active discussions are ongoing ...and a 70p takeout is quite possible!!”

Yesterday.......

“If there's an offer - maximum 25p.”

Wednesday..........

“Might get 15p donmac, no interest what so ever here.”

2nd Feb

“I would not be surprised if the FSA also look into all of this!. Any bid will be 25p tops!.”

9 dyas ago............

“will not be surprised to see the 'End of FSP' Rns soon.”

What did you expect ? Massive buying ?

Today is just another tck in the box that was needed. Funding secured. Move on to selling the business.
Most of the sales are held by board and investment companies. Not private investors.
Why would they carry on buying and increase exposure when they will be offered a price for their holdings ?

Just sit tight.

I agree with you Pensioner. I bought some more after open.

Doing dummy sales later, I was quoted above the mid price every time.
They wanted stock but weren't reflecitng on the bid shown.

Even LSE trades only show 2 sells.

I'm using ADVFN Level to subscribed so live feed of MMs too.
It was alsmot all buying hence rising from the lower open.

'lots of sells' ????

I dont know where you are looking but out of 51 trades trades today, only 2 are showing as sells.

There are 3 mm’s on the bid but only one on the offer. So going up to 19.5 next.
That’s why you can’t buy.
Not much stock to sell at 19p and only one MM.

Spread just jumped to 1.5p as PLHC will pay you 18.5p now with a bid for 10k shares.

Looks like they want stock now.

It's not clear who the debtor is. I suspect it may be Excalibur.
They had a contract with them for a minimum payment. I suspect that it has not reached sales expected by excalibur so they (excalibur) want to reneg that payment. Was that the debt ?
It was also an exclusive deal with excalibur so looks like Sens dropped the money owed and in return get to license Magnifeye to other businesses.

below is the relevent part of the RNS. The paragraph after then talks about a debtor but does not say who it was.

"On 25 January 2022 the Company and Excalibur Healthcare Services ("Excalibur") agreed to amend the terms of the Licence and Development Agreement signed 9 February 2021. Pursuant to the amended terms, Excalibur's licence to use MagnifEye becomes non-exclusive with immediate effect. The Company will continue to receive a royalty on sales made by Excalibur, but guaranteed minimum royalties are removed. The Company will now seek additional commercial partners for MagnifEye, which comprises a suite of eight algorithms that can be used to automate and improve the accuracy of reading lateral flow diagnostic tests, with applicability beyond COVID-19 to a wide range of industrial applications, both clinical and non-clinical. Excalibur can also market and partner its own tests with MagnifEye to existing and new customers for all applications. "

The 6 million sell was Amati Global Investors Ltd.

Just releaased RNS. They must have made a huge loss.

Over 6 million sell at 20p !

We haven't reached the bottom then ................

Well I’m trying to top up £2k worth and can’t even get a quote !

I managed to get 80k at 2.46.

I had to try over a couple of hours as could not get a quote to buy for some time.

Just tried to buy more and quoted 2.47p. Was 2.305 yesterday before close.

I’ll wait and see if I can get 2.3.

I’m with HLso usually get close to the mid price which is 2.3.
Just that the spread is still wide 0.4 which gives a 16% loss as soon as I buy !

This is the problem with a .4 or .5 spread.

I don’t think there is much stock to buy hence having to pay more.
They need to raise the bid. It’s silly as they aren’t ‘making a market’.

A spread of almost 20% is ridiculous.

Eephaven. Keep up……that’s been on there since day one back in the spring.

To do day 2/8 you have to register on the recova system as the test is sent specifically for you and you get a reference number. When travelling back to the uk, you can’t board without the reference number to show you have a kit ordered. A friend of mine was denied boarding and spent 2 days waiting to get back. If you just but the PCR kit shown, all you get is to test at home, not linked to a mandatory test.

Excellent bit of targeting on students. A huge market.

Shows they are thinking wider on sales and outside the box.

Sorry, I’ll spell check next time before posting.
In a hurry to go out.

Fair enough. I know you mention they are just shout Covid.

Point is they are a healthcare company and exploited the opportunity to go into the test market.
Plenty if companies get into markets that are short lived or trends.
Look at Filofax and what they sold for.
If no one got in to long term markets then no one would sell Xmas tress each year.
That’s pretty seasonal.

MHC we’re on target for 12 million revenue up to and including 3rd quarter I recall.
Even if you guess the last quarter as a third of the third quarter revenue then we are looking at around 15 million revenue. Cash positive in the third quarter and millions in cash.
PCR will keep the company ticking over and enable the launch if the new products.
They e set their own lab up paid for by PCR revenue which will now be good to go for new product launch.

I seen little downside and results should be amazing and demonstrate longevity.
The next trading update for year end must have launch date for new products to keep momentum going.

Bakky. I am assuming you are talking this down as you want to buy in cheaper so continually posting negative comments.